The global biotechnology nanoparticles industry is forecast to report strong revenue growth during the period 2012 to 2017 as companies invest heavily in drug development and the early implementation and heavy testing of new nano-coated and nanoparticle-based drugs. The biotechnology nanoparticles market is forecast to increase at a CAGR of 19.9% during 2012 to 2017 with the industry being valued at US$21.6 billion by the end of 2012, increasing to US$53.5 billion by 2017.
Parvus Therapeutics is currently implementing a significant testing and development programme as the company attempts to make breakthroughs in nanomedicines in the hope to cure difficult-to-treat autoimmune diseases like Type 1 diabetes and multiple sclerosis. Ultra-small nanoparticles coated with immune system proteins are being designed by Parvus to leverage some of our natural defences; the implementation of nanotechnology in biotechnology is placing a demanding regulatory and lengthy testing process on these companies.
In terms of drug delivery systems, this part of the nanoparticles industry is forecast to increase from a value of US$11.3 billion in 2012 to US$30.9 billion in 2017. Drug development and formation for the application of nanoparticles in this sector is forecast to also increase from US$9.4 billion in 2012 to US$20.5 billion in 2017.
The biotechnology nanoparticles market is associated with a long drug development phase or phases with signficantly longer testing periods and stringent regulations before the drug can reach the end user. This places much emphasis on drug development selection and the implementation of effective strategies by companies in choosing the right programme to be undertaken.
For more information on the biotechnology nanoparticles market, see the latest research: Biotechnology Nanoparticles Market
Follow us on Twitter @CandMResearch
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.